Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mayersohn

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
The Journal of Pediatrics|August 1, 1994
Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adultsR C Dart, K M Hurlbut, R M Maiorino, et al.
Biopharmaceutics & Drug Disposition|April 1, 1994
The effect of hepatic disease on the disposition of moricizine in humansH J Pieniaszek, A F Davidson, C M McEntegart, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteersK M Hurlbut, R M Maiorino, M Mayersohn, et al.
Journal of Clinical Pharmacology|May 1, 1983
Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysisF J Kogan, R E Sampliner, M Mayersohn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1996
Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 ratT L Ziegler, U A Pillai, R L Smith, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney functionK Stoeckel, J P Pfefen, M Mayersohn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1997
Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouseJ M Sauer, J Bao, R L Smith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1996
3,3',4,4'-tetrachloroazobenzene absorption, disposition, and metabolism in male Fischer 344 ratsU A Pillai, T L Ziegler, D X Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 1, 1997
Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 ratJ M Sauer, R L Smith, J Bao, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Bleomycin pharmacokinetics in man. I. Intravenous administrationD S Alberts, H S Chen, R Liu, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
The Journal of Pediatrics|August 1, 1994
Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adultsR C Dart, K M Hurlbut, R M Maiorino, et al.
Biopharmaceutics & Drug Disposition|April 1, 1994
The effect of hepatic disease on the disposition of moricizine in humansH J Pieniaszek, A F Davidson, C M McEntegart, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteersK M Hurlbut, R M Maiorino, M Mayersohn, et al.
Journal of Clinical Pharmacology|May 1, 1983
Cimetidine disposition in patients undergoing continuous ambulatory peritoneal dialysisF J Kogan, R E Sampliner, M Mayersohn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1996
Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 ratT L Ziegler, U A Pillai, R L Smith, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney functionK Stoeckel, J P Pfefen, M Mayersohn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1997
Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouseJ M Sauer, J Bao, R L Smith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1996
3,3',4,4'-tetrachloroazobenzene absorption, disposition, and metabolism in male Fischer 344 ratsU A Pillai, T L Ziegler, D X Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 1, 1997
Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 ratJ M Sauer, R L Smith, J Bao, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Bleomycin pharmacokinetics in man. I. Intravenous administrationD S Alberts, H S Chen, R Liu, et al.
Pageof 13